Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Vatreptacog alfa (activated)

EU orphan designation number: EU/3/12/1030
Active ingredient: Vatreptacog alfa (activated)
Indication: Treatment of haemophilia A
Sponsor: Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Orphan designation EMA/OD/069/12 (2012)5794 of 09/08/2012
08/09/2014 Removal of orphan designation from Community Register